NCT02606097View on ClinicalTrials.gov

Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Gastrointestinal Stromal Tumour (GIST)
Interventions
DRUG

regorafenib

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02606097 - Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation | Biotech Hunter | Biotech Hunter